It has been further reported that a pan-histone deacetylase inhibitor Vorinostat as well as a class I selective histone deacetylase inhibitor Romidepsin downregulates CCR4 expression in ATLL [113]. Here, CCR4 is linked to adult T-cell leukemia/lymphoma.